Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 104.09

-1.3%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (2734)	3/10/2012 2:18:46 PM
From: Biotech Jim	of 3202

Nice to see the human mass balance study is completed, Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects Nice to see the progress on the human QT cardiac study, A Study of LY3009104 in Healthy Volunteers The other studies are efficacy studies, so I look forward to the psoriasis read. I think we will really see the LLY clinical machine once in Ph3 for both RA and psoriasis. What's up with the Japanese RA population study? Are they getting the study going to start the more arduous Japanese filing, or is there something special about PK in the Japanese population? I see there are secondary endpoints in this study for drug exposure.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next